Cite
Walsh SP, Shahripour A, Tang H, et al. Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation. ACS Med Chem Lett. 2015;6(7):747-52doi: 10.1021/ml500440u.
Walsh, S. P., Shahripour, A., Tang, H., Teumelsan, N., Frie, J., Zhu, Y., Priest, B. T., Swensen, A. M., Liu, J., Margulis, M., Visconti, R., Weinglass, A., Felix, J. P., Brochu, R. M., Bailey, T., Thomas-Fowlkes, B., Alonso-Galicia, M., Zhou, X., Pai, L. Y., Corona, A., Hampton, C., Hernandez, M., Bentley, R., Chen, J., Shah, K., Metzger, J., Forrest, M., Owens, K., Tong, V., Ha, S., Roy, S., Kaczorowski, G. J., Yang, L., Parmee, E., Garcia, M. L., Sullivan, K., & Pasternak, A. (2015). Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation. ACS medicinal chemistry letters, 6(7), 747-52. https://doi.org/10.1021/ml500440u
Walsh, Shawn P, et al. "Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation." ACS medicinal chemistry letters vol. 6,7 (2015): 747-52. doi: https://doi.org/10.1021/ml500440u
Walsh SP, Shahripour A, Tang H, Teumelsan N, Frie J, Zhu Y, Priest BT, Swensen AM, Liu J, Margulis M, Visconti R, Weinglass A, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Alonso-Galicia M, Zhou X, Pai LY, Corona A, Hampton C, Hernandez M, Bentley R, Chen J, Shah K, Metzger J, Forrest M, Owens K, Tong V, Ha S, Roy S, Kaczorowski GJ, Yang L, Parmee E, Garcia ML, Sullivan K, Pasternak A. Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation. ACS Med Chem Lett. 2015 May 07;6(7):747-52. doi: 10.1021/ml500440u. eCollection 2015 Jul 09. PMID: 26191360; PMCID: PMC4499836.
Copy
Download .nbib